Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients ; volume:110 ; number:8 ; day:9 ; month:7 ; year:2021 ; pages:1142-1149 ; date:8.2021
Clinical research in cardiology ; 110, Heft 8 (9.7.2021), 1142-1149, 8.2021
- Creator
-
Schramm, René
Costard-Jäckle, Angelika
Rivinius, Rasmus
Fischer, Bastian
Müller, Benjamin
Boeken, Udo
Haneya, Assad
Provaznik, Zdenek
Knabbe, Cornelius
Gummert, Jan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-021-01880-5
- URN
-
urn:nbn:de:101:1-2021102501513193412361
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schramm, René
- Costard-Jäckle, Angelika
- Rivinius, Rasmus
- Fischer, Bastian
- Müller, Benjamin
- Boeken, Udo
- Haneya, Assad
- Provaznik, Zdenek
- Knabbe, Cornelius
- Gummert, Jan
- SpringerLink (Online service)
Other Objects (12)
Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
The cardiothoracic surgeon
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Journal of cardiothoracic surgery
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
The cardiothoracic surgeon
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Journal of cardiothoracic surgery
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
The cardiothoracic surgeon
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Journal of cardiothoracic surgery
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study